Advin Biotech integrates cutting-edge scientific research to drive innovation. Our key innovations include:
A removable vessel within the cup collects and retains a pristine specimen for confirmation testing or regulatory compliant storage.
A version of the iSplit Cup that reduces accessioning time in the lab by integrating a removable specimen tube that can go directly into a liquid handler.
Newly engineered and patented dipcard design to improve speed and efficiency for batch testing multiple specimens.
Proprietary equipment to automate manufacturing steps are designed and built in-house.
We deliver novel, cutting -edge solutions to improve testing efficiency in the diverse toxicology market.
Our drugs of abuse tests are manufactured in the U.S., ensuring fast delivery and premium quality.
Our FDA registered IVD manufacturing facility complete with proprietary automated manufacturing processes ensure consistent batch to batch quality of all our product lines.
We provide tailored pricing solutions based on the needs of our clients.
All products may be privately labelled for our valued distribution partners and customized cut-off levels are available to meet your unique requirements.
In-house toxicologists are ready to help troubleshoot or answer questions.
Our products test for all of the most popular drugs of abuse in a variety of combinations including all standard assays, as well as tests for EtG, Tramadol, Fentanyl, Ketamine, and the first US FDA cleared 6AM test. Our CLIA-waived and FDA-approved tests are customizable, to meet a wide range of cutoff levels and we keep pace with fast-paced industry needs by regularly introducing novel drug tests.
Most tests are U.S. FDA cleared to be 99.9% accurate, as well as CLIA waived and approved for home use, certifying that they are sufficiently simple to operate and interpret. Any test we make that could be considered a niche test, for which the FDA has not yet established guidelines, is held to this same standard and will be cleared after protocols are established by the FDA.
Negative results may be seen in as little as one minute. Positive results may be read after 5 minutes. Results should not be read after 60 minutes.
Some tests do not distinguish between therapeutic use of a drug and abuse of the same drug. A test may yield preliminary positive results when prescription tricyclic antidepressants, barbiturates, benzodiazepines, methadone, buprenorphine or opiates are ingested, even at therapeutic doses. There are no uniformly recognized drug levels for these prescription drugs in urine.
Room temperature storage, or 2-30 degrees Celsius / 35.6-86 degrees Fahrenheit is recommended. Do not freeze the test. The expiration date is written on the pouch that contains the device, and the shelf life is 2 years from the date of manufacture.
